ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
131,840
131,840
98,267
107,712
106,795
Cost of revenue
102,440
102,440
73,625
78,553
75,630
Gross profit
29,400
29,400
24,642
29,159
31,165
Operating expenses
Research development
7,081
7,081
6,826
5,947
6,805
Selling general and administrative
22,190
22,190
17,781
17,511
16,992
Total operating expenses
29,271
29,271
24,607
23,458
23,797
Operating income or loss
129
129
35
5,701
7,368
Interest expense
951
951
242
436
539
Total other income/expenses net
376
-575
-186
1,322
-597
Income before tax
-446
-446
-151
7,023
6,771
Income tax expense
-326
-326
79
1,692
1,457
Income from continuing operations
-120
-120
-230
5,331
5,314
Net income
-119
-119
-234
5,232
5,205
Net income available to common shareholders
-119
-119
-234
5,232
5,205
Basic EPS
-
-
-0.01
0.33
0.33
Diluted EPS
-
-
-0.01
0.33
0.32
Basic average shares
-
-
16,037
15,902
15,783
Diluted average shares
-
-
16,037
16,096
16,179
EBITDA
-
129
35
5,701
7,368